Loading...
Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is a rare orphan disease with a dismal prognosis. Surgery remains the first-line treatment, but most patients eventually develop metastatic disease. Mitotane is often used with chemotherapy with modest success. Little information is available concerning the efficacy of...
Saved in:
| Published in: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Endocrine Society
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853671/ https://ncbi.nlm.nih.gov/pubmed/31745526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|